Literature DB >> 8398189

Cardiac dysrhythmia in total thoracic oesophagectomy. A prospective study.

A J Ritchie1, M Whiteside, M Tolan, J A McGuigan.   

Abstract

A prospective controlled randomized clinical study of 50 patients undergoing total thoracic oesophagectomy by one surgical team is described, in which one group of patients was given prophylactic digoxin and the other was not. The incidence of cardiac dysrhythmia in each group was compared. Fourteen (56%) of 25 patients digitalized, compared to 16 (64%) of 25 patients not digitalized, suffered cardiac dysrhythmia, with a total incidence of 30 patients (60%). The first onset of dysrhythmia occurred within 48 h in 89% of the patients who suffered this complication. These results indicate a high incidence of cardiac dysrhythmia in patients undergoing this operative procedure, which is not significantly reduced by prophylactic digitalization and which is likely to occur within 2 days of surgery.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8398189     DOI: 10.1016/1010-7940(93)90006-w

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  3 in total

1.  Atrial fibrillation after esophageal cancer surgery: an analysis of 207 consecutive patients.

Authors:  Toshiyasu Ojima; Makoto Iwahashi; Mikihito Nakamori; Masaki Nakamura; Masahiro Katsuda; Takeshi Iida; Keiji Hayata; Hiroki Yamaue
Journal:  Surg Today       Date:  2013-05-15       Impact factor: 2.549

2.  Incidence and Risk Factors of an Intraoperative Arrhythmia in Transhiatal Esophagectomy.

Authors:  Mojtaba Ahmadinejad; Mozaffar Hashemi; Abbas Tabatabai; Shahram Keykha; Zabihollah Taleshi; Koorosh Ahmadi
Journal:  Iran Red Crescent Med J       Date:  2015-12-26       Impact factor: 0.611

3.  Risk factors for an intraoperative arrhythmia during esophagectomy.

Authors:  Tae-Soo Hahm; Jeong-Jin Lee; Mi-Kyung Yang; Jie-Ae Kim
Journal:  Yonsei Med J       Date:  2007-06-30       Impact factor: 2.759

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.